IP Library › Granted Patent US 11,834,689
Granted Patent B2
US 11,834,689 · App. 17/196,151 · Granted Dec 5, 2023

Incorporation of unnatural nucleotides and methods thereof

Inventors: Jerod Ptacin (La Jolla, CA); Carolina Caffaro (La Jolla, CA); Hans Aerni (La Jolla, CA); Yorke Zhang (La Jolla, CA); Emil C. Fischer (La Jolla, CA); Aaron W. Feldman (La Jolla, CA); Vivian T. Dien (La Jolla, CA); Floyd E. Romesberg (La Jolla, CA)
Assignees: THE SCRIPPS RESEARCH INSTITUTE; SYNTHORX, INC.
C12N9/93C12N15/113C12N15/90C12P21/02C12Y601/01026
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,834,689
App. No.
17/196,151
Granted
Dec 5, 2023
Kind
B2
Abstract

Disclosed herein are methods, compositions and kits for the synthesis of proteins which comprises unnatural amino acids that utilize a mutant tRNA.

Claims (32)

1. A cell comprising:

a. a nucleoside triphosphate transporter from Phaeodactylum tricornutum;

b. a tRNA from Methanosarcina mazei or Methanococcus jannaschii comprising an anticodon, wherein the anticodon comprises a sequence selected from GGY, GYG, YGG, GAY, GYA, YGA, GCY, GYC, YGC, GUY, GYU, YGU, CAY, CYA, YCA, CGY, CYG, YCG, CUY, CYU, YCU, CCY, CYC, YCC, AAY, AYA, YAA, AGY, AYG, YAG, ACY, AYC, YAC, AUY, AYU, YAU, UUY, UYU, YUU, UAY, UYA, YUA, UGY, UYG, YUG, UCY, UYC, YUC, GYY, YGY, YYG, CYY, YCY, YYC, AYY, YAY, YYA, UYY, YUY, YYU, YYY, GGX, GXG, XGG, GAX, GXA, XGA, GCX, GXC, XGC, GUX, GXU, XGU, CAX, CXA, XCA, CGX, CXG, XCG, CUX, CXU, XCU, CCX, CXC, XCC, AAX, AXA, XAA, AGX, AXG, XAG, ACX, AXC, XAC, AUX, AXU, XAU, UUX, UXU, XUU, UAX, UXA, XUA, UGX, UXG, XUG, UCX, UXC, XUC, GXX, XGX, XXG, CXX, XCX, XXC, AXX, XAX, XXA, UXX, XUX, XXU, or XXX, and wherein each of Y and X are an unnatural nucleotide comprising an unnatural nucleobase selected from

c. an aminoacyl tRNA synthetase from Methanosarcina or Methanococcus jannaschii ; and

d. an mRNA comprising a codon, wherein the codon comprises a sequence selected from GGY, GYG, YGG, GAY, GYA, YGA, GCY, GYC, YGC, GUY, GYU, YGU, CAY, CYA, YCA, CGY, CYG, YCG, CUY, CYU, YCU, CCY, CYC, YCC, AAY, AYA, YAA, AGY, AYG, YAG, ACY, AYC, YAC, AUY, AYU, YAU, UUY, UYU, YUU, UAY, UYA, YUA, UGY, UYG, YUG, UCY, UYC, YUC, GYY, YGY, YYG, CYY, YCY, YYC, AYY, YAY, YYA, UYY, YUY, YYU, YYY, GGX, GXG, XGG, GAX, GXA, XGA, GCX, GXC, XGC, GUX, GXU, XGU, CAX, CXA, XCA, CGX, CXG, XCG, CUX, CXU, XCU, CCX, CXC, XCC, AAX, AXA, XAA, AGX, AXG, XAG, ACX, AXC, XAC, AUX, AXU, XAU, UUX, UXU, XUU, UAX, UXA, XUA, UGX, UXG, XUG, UCX, UXC, XUC, GXX, XGX, XXG, CXX, XCX, XXC, AXX, XAX, XXA, UXX, XUX, XXU, or XXX, and wherein each of Y and X are an unnatural nucleotide comprising an unnatural nucleobase selected from

and wherein the anticodon of the tRNA pairs with the codon of the mRNA.

2. The cell of claim 1 , wherein the cell further comprises an oligonucleotide encoding the tRNA.

3. The cell of claim 1 , wherein the cell further comprises an oligonucleotide encoding the aminoacyl tRNA synthetase.

4. The cell of claim 1 , wherein the cell further comprises an oligonucleotide encoding the mRNA.

5. The cell of claim 1 , wherein the cell further comprises an oligonucleotide that encodes the tRNA and the mRNA.

6. The cell of claim 1 , wherein the cell further comprises an oligonucleotide that encodes the tRNA, the mRNA, and the aminoacyl tRNA synthetase.

7. The cell of claim 1 , wherein the unnatural nucleobase in the anticodon is

and the unnatural nucleobase in the codon is

8. The cell of claim 7 , wherein the unnatural nucleobase in the codon is

and the unnatural nucleobase in the anticodon is

9. The cell of claim 1 , wherein the anticodon comprises the sequence GYT or GYC, wherein Y comprises the unnatural nucleobase.

10. The cell of claim 9 , wherein the unnatural nucleobase of Y is

11. The cell of claim 10 , wherein the unnatural nucleobase of Y is

12. The cell of claim 10 , wherein the unnatural nucleobase of Y is

13. The cell of claim 1 , wherein the codon comprises the sequence AXC or GXC, wherein X comprises the unnatural nucleobase.

14. The cell of claim 13 , wherein the codon comprises the sequence AXC.

15. The cell of claim 14 , wherein the unnatural nucleobase of X is

16. The cell of claim 14 , wherein the unnatural nucleobase of X is

17. The cell of claim 13 , wherein the codon comprises the sequence GXC.

18. The cell of claim 17 , wherein the unnatural nucleobase of X is

19. The cell of claim 17 , wherein the unnatural nucleobase of X is

20. The cell of claim 1 , wherein the aminoacyl tRNA synthetase is from Methanosarcina barkeri.

21. The cell of claim 1 , wherein the aminoacyl tRNA synthetase is from Methanococcus jannaschii.

22. The cell of claim 1 , wherein the aminoacyl tRNA synthetase is a pyrrolysyl tRNA synthetase.

23. The cell of claim 1 , wherein the aminoacyl tRNA synthetase is a tyrosyl tRNA synthetase.

24. The cell of claim 1 , wherein the cell is a microorganism or bacterium.

25. The cell of claim 1 , wherein the cell is an E. coli cell.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2025
From: SYNTHORX, INC.
To: SANOFI
Reel/Frame 073718/0079 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2021
From: PTACIN, JEROD; CAFFARO, CAROLINA; AERNI, HANS
To: SYNTHORX, INC.
Reel/Frame 056036/0323 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2021
From: ZHANG, YORKE; FISCHER, EMIL C.; FELDMAN, AARON W.; DIEN, VIVIAN T.; ROMESBERG, FLOYD E.
To: THE SCRIPPS RESEARCH INSTITUTE
Reel/Frame 056036/0433 →
Continuity (3)
Continuation 16629255
Provisional Application 62531325 · Jul 11, 2017
Related Publication 20210222147A1 · Jul 22, 2021
Cited By (3)
US 12,319,944 US 12,497,642 US 12,655,436